Interferon alpha-2b and thalidomide in previously treated patients with disseminated malignant melanoma: SWOG 0026.

被引：0
|
作者：
Hutchins, L
Moon, J
Clark, J
Thompson, J
Yost, K
Sondak, V
机构：
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[2] SW Oncol Grp, Ctr Stat, Seattle, WA USA
[3] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Grand Rapids CCOP, Grand Rapids, MI USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：716S / 716S
页数：1
相关论文
共 50 条
  • [1] Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026
    Hutchins, Laura F.
    Moon, James
    Clark, Joseph I.
    Thompson, John A.
    Lange, Marianne K.
    Flaherty, Lawrence E.
    Sondak, Vernon K.
    CANCER, 2007, 110 (10) : 2269 - 2275
  • [2] Neuropsychiatric Complications Associated with Interferon - Alpha-2b treatment of Malignant Melanoma
    Enudi, W.
    Udolu, O. J.
    AFRICAN JOURNAL OF PSYCHIATRY, 2009, 12 (03) : 227 - 228
  • [3] MALIGNANT-MELANOMA - TREATMENT OF METASTATIC MENINGITIS WITH INTRATHECAL INTERFERON ALPHA-2B
    DORVAL, T
    BEUZEBOC, P
    GARCIAGIRALT, E
    JOUVE, M
    PALANGIE, T
    POUILLART, P
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) : 244 - 245
  • [4] Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2b
    Kayler, LK
    Merion, RM
    Arenas, JD
    Magee, JC
    Campbell, DA
    Rudich, SM
    Punch, JD
    TRANSPLANTATION, 2002, 74 (01) : 128 - 130
  • [5] Histamine metabolism in mastocytosis patients treated with interferon alpha-2b
    Granerus, G
    Lonnqvist, B
    Roupe, G
    INFLAMMATION RESEARCH, 1996, 45 : S41 - S43
  • [6] Low-dose thalidomide and interferon alpha-2b in patients with metastatic melanoma: The final results of a pilot study.
    Schlossberg, HR
    Solti, M
    Berd, D
    Mastrangelo, MJ
    Sato, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 727S - 727S
  • [7] INTERFERON ALPHA-2B FOR ESSENTIAL THROMBOCYTHEMIA - RESULTS IN 13 PREVIOUSLY UNTREATED PATIENTS
    CERVANTES, F
    SALGADO, C
    FELIU, E
    MONTSERRAT, E
    ROZMAN, C
    LEUKEMIA & LYMPHOMA, 1991, 4 (5-6) : 351 - 354
  • [8] Bortezomib and interferon alpha-2b in metastatic melanoma.
    Markowitz, Joseph
    Luedke, Eric A.
    Grignol, Valerie P.
    Hade, Erinn
    Paul, Bonnie K.
    Mundy-Bosse, Bethany L.
    Thao-Vi Dao
    Kondalasula, Vidya
    Lesinski, Gregory B.
    Olencki, Thomas
    Kendra, Kari Lynn
    Carson, William Edgar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma
    Garcia, Margarita
    del Muro, Xavier Garcia
    Tres, Alejandro
    Crespo, Carmen
    Valladares, Manuel
    Lopez, Juan Jose
    Rifa, Julio
    Perez, Xavier
    Filipovich, Elena
    Germa-Lluch, Josep Ramon
    MELANOMA RESEARCH, 2006, 16 (04) : 365 - 370
  • [10] Recombinant interferon alpha-2b in the management of malignant pleural effusions
    Wilkins, HE
    Connolly, MM
    Grays, P
    Marquez, G
    Nelson, D
    CHEST, 1997, 111 (06) : 1597 - 1599
12345